Skip to content
TheBrief.Health

Living with advanced solid tumors

Stories from people navigating advanced solid tumors — diagnosis, treatment, caregiving, and the ordinary days in between.

1 story

A pathology slide beside a molecular sequencing report highlighting a RET gene fusion

Oncology

Selpercatinib Expands RET Fusion Testing Across Tumors

Traditional approval makes selpercatinib an established tumor-agnostic option for qualifying RET fusion-positive advanced solid tumors in adults and children age 2 years and older.

Rayan Salih · August 25, 2026 · 7 min

Other conditions

One story a day

The story of the day, in your inbox

One health journey each morning — no advice, no alarm, just company for the road.